25 of the Best Pediatric Hematologist Oncologists Near Me

Jennifer Ann Kovatch, MD, is a board-certified physician specializing in pediatric hematology oncology.|Dr. Kovatch and her team treat children up to age 13 for conditions such as leukemia/lymphoma, solid tumors, benign tumors and benign hematology (anemia, bleeding disorders and clotting disorders).|Dr. Kovatch performs procedures including lumbar puncture, intrathecal chemotherapy (when chemotherapy is delivered into cerebrospinal fluid), and bone marrow aspiration and biopsy.|She was inspired by her own experience as a pediatric hematology oncology patient to pursue a career in medicine and make a difference in the lives of children. “I love getting to know my patients and helping them achieve their therapeutic goals,” she says.|Dr. Kovatch earned her Doctor of Medicine from the Ross University School of Medicine in the West Indies in 2014. She completed her residency at the University of Missouri in 2017 and a fellowship at the Penn State College of Medicine in 2020.|She is board certified in pediatrics and pediatric hematology oncology by the American Board of Pediatrics.|A New Jersey native, Dr. Kovatch enjoys renovating her home, yardwork and fostering cats in her spare time. Her hobbies include riding her motorcycle and creating artwork. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1). Dr. Kovatch is currently accepting new patients.

Dr. Grana specializes in pediatric hematology/oncology in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital medical staff in 1992. Dr. Grana earned her medical degree from the University of Puerto Rico School of Medicine. She trained in pediatrics at University Children’s Hospital in San Juan, Puerto Rico, and completed a pediatric hematology/oncology fellowship at the University of Florida. Her clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP). Dr. Grana is board certified in American Board Of Pediatrics.

Dimarys Sanchez is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL) and Immune Thrombocytopenic Purpura (ITP). Dr. Sanchez is board certified in American Board Of Pediatrics.

Adam Wolfe is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. His clinical expertise encompasses Hepatoblastoma and Acute Lymphoblastic Leukemia (ALL). Dr. Wolfe is board certified in American Board Of Pediatrics.

My interests and activities include spending time with my family, discovering new restaurants, and traveling. His clinical expertise encompasses Febrile Neutropenia and Neurofibromatosis Type 1 (NF1). Dr. Rajaram is board certified in American Board Of Pediatrics. Dr. Rajaram is currently accepting new patients.

Dr. Cruz Flores is a pediatric oncologist at Johns Hopkins All Children’s. She joined the hospital staff in 2020. She earned her medical degree from the University of Puerto Rico School of Medicine. She completed an internship and residency in pediatrics at the University of Puerto Rico School of Medicine, where she also served as chief resident. She completed a fellowship in pediatric hematology-oncology at Louisiana State University Health Sciences Center/Children’s Hospital New Orleans, followed by a fellowship in pediatric neuro-oncology at Johns Hopkins All Children’s. Her clinical expertise encompasses Glioma, Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1). Dr. Flores is board certified in American Board Of Pediatrics.

Dr. Miller is a board-certified and fellowship-trained specialist in pediatric hematology/oncology. She attended Eastern Virginia Medical School, where she received her medical degree. She completed her residency at Geisinger Medical Center and her fellowship in pediatric hematology and oncology at the University of Iowa Hospitals and Clinics. Dr. Miller is certified by the American Board of Pediatrics in pediatric hematology-oncology. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Neurofibromatosis Type 1 (NF1), and Immune Thrombocytopenic Purpura (ITP). Dr. Miller is board certified in The American Board Of Pediatrics In Pediatric Hematology-Oncology. Dr. Miller is currently accepting new patients.

Dr. Oshrine specializes in blood and marrow transplants as a pediatric hematologist/oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. His clinical focus is in the treatment of high-risk leukemias with blood and marrow transplantation, and his research focus is in immune recovery after transplant. He joined the hospital in 2014 after completing a fellowship in pediatric hematology/oncology at the Children’s Hospital of Philadelphia. He received the Excellence in Service & Professionalism Award in the 2018 Johns Hopkins Medicine Clinical Excellence Awards. Dr. Oshrine is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Gastrostomy. Dr. Oshrine is board certified in American Board Of Pediatrics.

Joseph Neglia is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Neglia is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Hereditary Retinoblastoma, and Splenectomy. Dr. Neglia is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986. Dr. Neglia is currently accepting new patients.

Rafat Ahmed is an Internal Medicine specialist and a Pediatric Hematologist Oncology provider practicing medicine in Camden, New Jersey. She has been practicing medicine for over 29 years. Dr. Ahmed is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Anemia, Hemolytic Anemia, Infantile Neutropenia, Congenital Hemolytic Anemia, and Bone Marrow Transplant. Dr. Ahmed is board certified in American Board Of Pediatrics,Pediatric Hematology,Oncology , 2013 and American Board Of Pediatrics,Pediatrics , 2008.

Elizabeth Yang is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 39 years. Dr. Yang is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Yang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1994 and Pediatrics: American Board Of Pediatrics, 1990.

Alexander Boucher is a Hematologist and a Pediatrics provider practicing medicine in Minneapolis, Minnesota. Dr. Boucher is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Hemoglobinopathy, Islet Cell Transplantation, and Pancreatectomy. Dr. Boucher is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021, Pediatrics: American Board Of Pediatrics, 2017, and Internal Medicine: American Board Of Internal Medicine, 2016. Dr. Boucher is currently accepting new patients.

Dr. Neethu Menon finished her medical degree and a residency at Maulana Azad Medical College in New Delhi, India. She completed a second residency at the University of Arizona College of Medicine, followed by a fellowship in pediatric hematology-oncology at UT Southwestern Medical Center in Dallas. Dr. Menon has been in practice since 2006. Board certified in both pediatrics and pediatric hematology-oncology, she treats children and young women for a variety of blood disorders. Her primary clinical interests include anemia, sickle cell disease, bleeding disorders and thrombosis. She is affiliated with the pediatrics faculty at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and has contributed, written and presented on hematology-related topics including sickle cell anemia, thrombosis and bleeding disorders. Away from her practice, Dr. Menon enjoys music and practices yoga. Dr. Menon is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia.

"In her first decade as a pediatric oncologist, Dr. Symons already has shown an impressive ability to juggle multiple research projects, in addition to caring for patients. One of Dr. Symons' research pursuits focuses on using a novel immunotherapy approach to treating both solid tumors and hematologic (blood-borne) malignancies. The basis of her work stems from the theory that cancer patients' immune systems should recognize tumor cells as foreign and destroy them. This doesn't happen, theorizes Dr. Symons, because the immune system attacks only those cells it perceives as dangerous—not cancer cells, which it sees simply as foreign. That's where her research comes into play. Evaluating an experimental therapy, Dr. Symons is pairing donor lymphocytes (white blood cells that activate the body's immune system) with chemotherapy to determine if this combination will ""awaken"" patients' immune systems to the danger of existing cancer cells and, in turn, elicit an immune response. In a separate yet equally compelling research endeavor, Dr. Symons is working to increase the availability of donors for children whose cancer requires bone marrow transplants (BMTs) as a potentially lifesaving treatment. ""It can be challenging to find a 'matched' donor,"" says Dr. Symons, who explains that only about 40 percent of patients who require a BMT find a matched donor. ""Sometimes, we don't have the benefit of time, because remissions can be short-lived. But almost all patients have a half-matched donor: a parent, sibling, or child,"" adds Dr. Symons, who is examining ways to reduce BMT-related complications ordinarily associated with half-matched donors after ablative (high dose) chemotherapy. ""Like anything else that's new, it will take some time to prove that this is a feasible option that's safe,"" she says. But she's optimistic. ""It has the potential to revolutionize BMT."" Dr. Symons knows it's worth the wait. ""Seeing the research I do in the lab translate into clinical trials, then seeing patients in these trials survive long term, is incredibly rewarding,"" she says.". Dr. Symons is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Aplastic Anemia, Anemia, Leukemia, and Bone Marrow Transplant. Dr. Symons is board certified in American Board Of Pediatrics.

Lucie Turcotte is a Pediatric Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Turcotte is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), and Basal Cell Skin Cancer. Dr. Turcotte is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015 and Pediatrics: American Board Of Pediatrics, 2010. Dr. Turcotte is currently accepting new patients.

Aditi Dhir is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in Miami, Florida. Dr. Dhir is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Osteosarcoma, Ewing Sarcoma, Hepatoblastoma, and Liver Embolization. Dr. Dhir is currently accepting new patients.

Miriam Garcia is a Pediatric Hematologist Oncology provider practicing medicine in Houston, Texas. She has been practicing medicine for over 14 years. Dr. Garcia is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Febrile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Ataxia-Telangiectasia.

Dr. Donald Small is the Kyle Haydock Professor of Oncology. He holds joint appointments in Pediatrics and Cellular and Molecular Medicine and Human Genetics. He also directs the Johns Hopkins/National Cancer Institute Pediatric Hematology/Oncology Fellowship program. Dr. Small received his undergraduate, and then M.D. and Ph.D. degrees from the Johns Hopkins University in 1979 and 1985. His Ph.D. research was conducted with Bert Vogelstein in the Oncology Department and his postdoctoral research with Tom Kelly in the Molecular Biology and Genetics Department. He trained in pediatrics and pediatric hematology/oncology at Johns Hopkins and joined the faculty in 1990. Dr. Small’s laboratory was the first to clone the human FLT3 gene that is the most frequently mutated gene in acute myeloid leukemia (AML) and results in very poor chances of cure for these patients. The investigations of FLT3 led Dr. Small and his team to discover drugs able to inhibit the cancer-generating activity of this important gene. His laboratory showed that a new class of drugs known as tyrosine kinase inhibitors could kill FLT3-affected cells, thus developing one of the earliest molecularly targeted cancer therapies. They then developed a test that enabled them to screen a host of additional kinase inhibitors and find several with great potency against FLT3. His group also led the first clinical trials investigating the use of a FLT3 inhibitor in adult relapsed and refractory FLT3 mutant AML, and determined how best to combine these drugs with chemotherapy. They also helped design the first pediatric trials of FLT3 inhibitors in pediatric AML and infant ALL. Dr. Small’s lab continues to investigate leukemic processes and the role of stem cells in governing the activities of the FLT3 gene in leukemia. Dr. Small is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, and Acute Lymphoblastic Leukemia (ALL).

Dr. Michelle Hudspeth is a 1999 graduate of the MUSC College of Medicine and completed her residency, chief residency, and fellowship at the Johns Hopkins Hospital and the National Cancer Institute. She is the division chief for pediatric hematology/oncology and is the director of the pediatric blood and marrow transplant program and the quality director for the combined adult and pediatric blood and marrow transplant program. Her main clinical focus is transplantation, including haploidentical, related and unrelated allogeneic, cord blood, and autologous donor sources. She is the institutional principal investigator for Pediatric Blood and Marrow Transplant Consortium trials. She is a member of the Pediatric Blood and Marrow Transplant Consortium GVHD committee and supportive care committee. She also serves on several working committees (GVHD, pediatric cancer, immune deficiencies/inborn errors of metabolism) for the Center for International Blood and Marrow Transplant Research. Her clinical research includes multiple aspects of transplantation, including a clinical trial incorporating pravastatin for matched related donor transplants for sickle cell disease. Dr. Hudspeth is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Infantile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Thymectomy.

Luca Szalontay is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Szalontay is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Brain Stem Cancer. Dr. Szalontay is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2015.

Urania Dagalakis, MD, MHSc, specializes in pediatric oncology and hematology. She completed her clinical training at Johns Hopkins University and conducted her research work within the National Cancer Institute of the National Institutes of Health. Due to her research background she specializes in caring for children with rare tumors and hereditary cancer syndromes. Dr. Dagalakis is the director of the Cancer Genetics Clinic at Children’s National Hospital. She is also an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences and a physician in the Center for Cancer and Blood Disorders. She is committed to empowering families with knowledge, supporting survivorship and leading innovations in personalized cancer care. Her work bridges compassionate patient care with clinical research focused on improving outcomes for children with genetic cancer predispositions. Dr. Dagalakis is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Hemoglobin SC Disease and Immune Thrombocytopenic Purpura (ITP). Dr. Dagalakis is board certified in Pediatrics: American Board Of Pediatrics, 2023.

Shana S. Jacobs, MD, is a member of the Leukemia/Lymphoma Program and the Pediatric Advanced Needs Assessment and Care Team (PANDA). Dr. Jacobs' clinical focus is on leukemia and lymphoma and she has an interest in palliative and supportive care. Publications PubMed. Dr. Jacobs is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Osteosarcoma, Malignant Peripheral Nerve Sheath Tumor, and Bone Marrow Transplant. Dr. Jacobs is board certified in American Board Of Pediatrics, 2010, Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006, and Pediatrics: American Board Of Pediatrics, 2002.

Hyojeong Han is a Transfusion Medicine specialist and a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Han is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Anemia, and Hemolytic Anemia. Dr. Han is board certified in American Board Of Pathology, 2021, American Board Of Pediatrics, 2021, and American Board Of Pediatrics, 2016.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Sayani Tewari is a Pediatric Hematologist Oncology provider practicing medicine in Dover, Delaware. She has been practicing medicine for over 4 years. Dr. Tewari is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Tetra-Amelia Syndrome, Alpha Thalassemia, Eyelid Bump, and Thalassemia. Dr. Tewari is board certified in American Board Of Pediatrics.